gemcitabine,pemetrexed,pembrolizumab
merck
['keynote,671', 'nsclc', 'ts,perio,1', 'pembro', 'sclc', 'ts,perio,i', 'keynote-671']
perioperative pembrolizumab regimen improves efs outcomes for patients with early-stage nsclc, according to findings from keynote-671. #asco23 
Capturing the voice of nursing professionals in the oncology news landscape.